Chinese pharmaceutical companies are stepping up their push into the US generic drugs market with the number of approvals for copycat medicines almost doubling last year.
manbetx3.0 制药公司正加大力度打入美国仿制药市场，去年manbetx3.0 药企获批的仿制药品种增加近一倍。
您已阅读4%（211字），剩余96%（4592字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。